Immune to Cancer: The CRI Blog
-
PORTER Immunotherapy Clinical Trial for Prostate Cancer Unveiled at SITC2019
Details of a promising new CRI co-funded clinical trial for metastatic prostate cancer unveiled at the 2019…
-
Cancer Research Institute Returns to Houston with an Immunotherapy Patient Summit for Third Time
On October 26, 2019, CRI hosted an Immunotherapy Patient Summit at MD Anderson Cancer Center for 120…
-
Liver Cancer Awareness Month: 2019 Immunotherapy Research Update
For Liver Cancer Awareness Month, we round up the latest news and research from the people changing…
-
Honoring a Legacy of Hope to Create a Future Immune to Cancer
At CRI's 33rd Annual Awards Dinner, philanthropic family legacies and scientific advances in cancer immunology received recognition…
-
Breast Cancer Awareness Month: 2019 Immunotherapy Research Update
For Breast Cancer Awareness Month, we round up the latest news and research from the people changing…
-
CICON19 Day 4 Update: Metabolic Crosstalk and the Microbiome
Day 4 of CICON19 highlighted breakthroughs in our understanding of the metabolic crosstalk within the tumor microenvironment as…
-
CICON19 Day 3 Update: Vaccines and Tumor Antigens, Technology and Informatics, and the Tumor Microenvironment
Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…
-
CICON19 Day 1 Update: Cancer Prevention and Combination Immunotherapy Strategies
Day 1 of CICON19 explored how checkpoint immunotherapy might be improved through combination strategies as well as…
-
Childhood Cancer Awareness Month: 2019 Immunotherapy Research Update
For Childhood Cancer Awareness Month, we round up the latest news and research from the people changing…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.